We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NiCox

News List

Nicox broadens two agreements with Ocumension in South East Asia pharmaceutical-technology
March 12, 2020
France-headquartered Nicox has expanded two licensing agreements with Chinese Ocumension Therapeutics for two ophthalmology drugs.
Nicox signs agreement for ZERVIATE in South Korea biospectrumasia
December 18, 2019
Samil Pharmaceutical will receive exclusive rights to develop and commercialize ZERVIATE in South Korea, where the market for allergic conjunctivitis was worth nearly €31 million for the 12 months to Q3 2019.
Nicox and Ocumension partner to develop and commercialise glaucoma drug pharmaceutical-technology
December 18, 2018
French ophthalmology firm Nicox has partnered with China-based Ocumension Therapeutics to develop and commercialise its NCX 470 for the treatment of patients with glaucoma or ocular hypertension......
Nicox pauses Nasdaq IPO plan amid market volatility fiercebiotech
November 02, 2018
Nicox has pulled out of a planned Nasdaq listing. The French biotech began gearing up to offer stock on Nasdaq earlier this year but has now hit pause on the plan in response to ...